se of bioreactance technology for early detection of reduced stroke volume during cesarean delivery under spinal anesthesia

• Conditions: O26.5; Maternal hypotension syndrome

• Registration Number: DRKS00033174
• Lead Sponsor: niversitätsklinikum Marburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-06
• Study Completion: 2024-04-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 60

Inclusion Criteria

Patients undergoing an elective caesarean delivery
- Spinal anaesthesia as an anaesthesia procedure for caesarean delivery
- Signed informed consent for inclusion in this study

Exclusion Criteria

- Patients < 18 years of age
- No SPA, but primarily general anaesthesia as the anaesthetic procedure for the caesarean section
- Patients who do not wish to participate in the examination (i.e. there is no signed consent form)
- Patients in whom the placement of the four adhesive electrodes is not possible for medical reasons (e.g. extensive wound or skin rash in the target area)
- Contraindications according to the manufacturer of the Starling monitor (Baxter)
- Presence of severe (clinically relevant) aortic valve insufficiency
- Severe anatomical anomalies of the thoracic aorta, e.g. (large) synthetic aortic grafts
- external / internal pacemakers with unipolar electrodes

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Does a reduction in stroke volume from a baseline value correlate with the phases of relevant hypotension?

Secondary Outcome Measures

Name	Time	Method
Systemic vascular resistance index (SVRI) / total peripheral resistance index (TPRI)<br>Heart rate (HR)<br>Cardiac Index (CI)<br>APGAR score of the child